Merck & Co., Inc.
145.60
3.22 (2.26%)
MRK
Price history
From Aug 22, 2025 to Oct 2, 2026, Merck & Co., Inc. ranged from 77.60 (low, Sep 25, 2025) to 156.4 (high, Aug 25, 2026) and last closed at 144.3, up 65.2% over the period.
| Performance | %Chg | Weekly | Monthly | YTD | YoY |
|---|---|---|---|---|---|
| Merck & Co., Inc. | 2.26% | -3.01% | -4.01% | 35.56% | 61.79% |
01
Latest Merck & Co., Inc. News
Merck's Keytruda Is Dealt a Legal Setback. It's Good News for This Biotech Stock. ↗
A Dutch court rules in favor of Halozyme Therapeutics, barring Merck from selling subcutaneous Keytruda in eight European markets.
Barrons · Oct 07, 12:20 UTC
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG ↗
NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on…
Globe News Wire · Oct 09, 18:56 UTC
Super Micro contractor pleads guilty in scheme to divert AI servers with Nvidia chips to China ↗
A contractor linked to Super Micro Computer has pleaded guilty in a scheme to illegally export computer servers containing advanced…
Reuters · Oct 09, 18:27 UTC
Wall Street nears bullish majority after gold's late-week rally, Main Street fails to reclaim bullish bias as inflation data take center stage ↗
The latest Kitco News Weekly Gold Survey showed Wall Street back on the brink of a bullish majority, while less than half of Main Street…
Kitco · Oct 09, 17:44 UTC
Amazon shuffles Alexa leadership following high-end tablet release ↗
Amazon on Friday confirmed it was shuffling leadership in its Alexa division, a day after the company announced its first tablet computers…
Reuters · Oct 09, 17:35 UTC
Lockheed Martin unveils PAC-3 Edge interceptor designed to counter hypersonic threats ↗
Lockheed Martin on Friday unveiled PAC-3 Edge, a missile interceptor designed to defend against hypersonic and advanced missile threats…
Reuters · Oct 09, 17:27 UTC
02
Related markets
| Name | Past year | Price | %Chg |
|---|---|---|---|
| AbbVie Inc. | 276.47 | 1.49% | |
| Abbott Laboratories | 99.60 | 1.13% | |
| Amgen Inc. | 414.87 | 1.82% | |
| Cigna Corporation | 282.43 | 0.50% | |
| Danaher Corporation | 219.87 | 1.11% | |
| Elevance Health Inc. | 412.70 | 2.93% | |
| Eli Lilly and Company | 1,179.3 | 0.83% | |
| Gilead Sciences, Inc. | 151.17 | 2.77% |